【レポートの概要（一部）】
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Disease overview
• Understanding the disease
• Economic burden
• Types of lung cancer
• Diagnosis
• Staging of SCLC
• Staging of NSCLC
• Key buying criteria
PART 06: Pipeline analysis
PART 07: Market landscape
• Global lung cancer therapeutics market
• Five forces analysis
PART 08: Market segmentation by disease type
• NSCLC
• Global NSCLC market overview
• SCLC
• Global SCLC market overview
PART 09: Market segmentation by type of molecule
• Small molecules
• Biologics
PART 10: Geographical segmentation
• Lung cancer therapeutics market in Americas
• Lung cancer therapeutics market in EMEA
• Lung cancer therapeutics market in APAC
PART 11: Market drivers
• Growing demand for targeted therapies
• Presence of blockbuster drugs coupled with longer patent exclusivities
• Advancements in identification of molecular biomarkers increasing patient pool
• Paradigm shifts toward the adoption of checkpoint inhibitors
PART 12: Impact of drivers
PART 13: Market challenges
• Growing popularity of alternative therapeutics
• High costs leading to low adoption rate
• Adverse effects of drugs
PART 14: Impact of drivers and challenges
PART 15: Market trends
• Emergence of nanomedicine platform for the treatment of lung cancer
• Advent of miRNA therapeutics in the treatment of lung cancer
• Growing strategic alliances for late-stage pipeline
• Growing approvals in lung cancer therapeutics market
PART 16: Vendor landscape
• Competitive scenario
PART 17: Key vendor analysis
• F. Hoffmann-La Roche
• Eli Lilly
• AstraZeneca
• Pfizer
• Celgene
• Other prominent vendors
PART 18: Appendix
• List of abbreviations
PART 19: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Key customer segments of global lung cancer therapeutics market
Exhibit 03: Snapshot of lung cancer
Exhibit 04: Types of lung cancer
Exhibit 05: Main diagnostic procedures to determine presence of lung cancer
Exhibit 06: Staging of SCLC
Exhibit 07: Illustration of stages of NSCLC disease
Exhibit 08: Key buying criteria for lung cancer therapeutics
Exhibit 09: Factors affecting adoption rates of lung cancer therapeutics
Exhibit 10: Pipeline analysis of key vendors in global lung cancer therapeutics market
Exhibit 11: Percentage share of drug candidates by stage of development
Exhibit 12: Phase III pipeline portfolio: Global lung cancer therapeutics market
Exhibit 13: Phase II pipeline portfolio: Global lung cancer therapeutics market
Exhibit 14: Phase I pipeline portfolio: Global lung cancer therapeutics market
Exhibit 15: Global lung cancer therapeutics market snapshot
Exhibit 16: Analysis of global lung cancer therapeutics market
Exhibit 17: Global lung cancer therapeutics market size and forecast 2015-2020 ($ billions)
Exhibit 18: Opportunity analysis of global lung cancer therapeutics market
Exhibit 19: Opportunity analysis in developed and emerging markets
Exhibit 20: Five forces analysis
Exhibit 21: Segmentation of global lung cancer therapeutics market by disease type 2015 and 2020
Exhibit 22: Life cycle analysis of key segments in global lung cancer therapeutics market 2015
Exhibit 23: Types of NSCLC
Exhibit 24: Potential drugs/drug candidates in global NSCLC therapeutics market
Exhibit 25: Key drivers impacting market growth in NSCLC
Exhibit 26: Global NSCLC therapeutics market size and forecast 2015-2020 ($ billions)
Exhibit 27: Opportunity analysis in global NSCLC market
Exhibit 28: Key points in SCLC
Exhibit 29: Key drivers impacting market growth in SCLC
Exhibit 30: Global SCLC therapeutics market size and forecast 2015-2020 ($ billions)
Exhibit 31: Opportunity analysis in global SCLC therapeutics market
Exhibit 32: Segmentation of global lung cancer therapeutics market by type of molecule 2015
Exhibit 33: Global lung cancer therapeutics market by geographical segmentation 2015-2020
Exhibit 34: Segmentation of global lung therapeutics market based on geography 2015 and 2020
Exhibit 35: Lung cancer therapeutics market revenue by geography 2015-2020 ($ billions)
Exhibit 36: Lung cancer therapeutics market in Americas 2015-2020 ($ billions)
Exhibit 37: Key trends across various countries in Americas
Exhibit 38: Lung cancer therapeutics market size and forecast in EMEA 2015-2020 ($ billions)
Exhibit 39: Drivers in lung cancer therapeutics market in EMEA
Exhibit 40: Key strategic initiatives in various countries in EMEA
Exhibit 41: Lung cancer therapeutics market size and forecast in APAC 2015-2020 ($ billions)
Exhibit 42: Key drivers and challenges in APAC
Exhibit 43: YoY growth rate of Avastin 2015
Exhibit 44: Performance of blockbuster drugs in 2015
Exhibit 45: Patent exclusivities of few blockbuster drugs
Exhibit 46: Recent launches of checkpoint inhibitors
Exhibit 47: Impact of drivers
Exhibit 48: Alternative therapies for lung cancer therapeutics
Exhibit 49: Costs of few lung cancer drugs ($)
Exhibit 50: Force field analysis of drivers and challenges in global lung cancer therapeutics market
Exhibit 51: Impact of drivers and challenges
Exhibit 52: Trend analysis in global lung cancer therapeutics market
Exhibit 53: Key factors driving adoption of nanomedicine
Exhibit 54: Factors driving adoption of miRNA therapeutics
Exhibit 55: Key deals in global lung cancer therapeutics market
Exhibit 56: Recent approvals of lung cancer therapeutics
Exhibit 57: Competitive analysis in global lung cancer therapeutics market
Exhibit 58: Market penetration of various lung cancer therapeutics manufacturers in global (2015)
Exhibit 59: Regional analysis of vendors in global lung cancer therapeutics market
Exhibit 60: Vendors ranking in global lung cancer therapeutics market
Exhibit 61: F. Hoffmann-La Roche: Key highlights
Exhibit 62: F. Hoffmann-La Roche: Strength assessment
Exhibit 63: F. Hoffmann-La Roche: Strategy assessment
Exhibit 64: F. Hoffmann-La Roche: Opportunity assessment
Exhibit 65: F. Hoffmann-La Roche: YoY growth and revenue generated from net product sales of Avastin 2013-2015 ($ billions)
Exhibit 66: F. Hoffmann-La Roche: Geographic segmentation of Avastin by revenue 2015
Exhibit 67: F. Hoffmann-La Roche: YoY growth and revenue generated from net product sales of Tarceva 2013-2015 ($ billions)
Exhibit 68: F. Hoffmann-La Roche: Geographic segmentation of Tarceva by revenue 2015
Exhibit 69: Eli Lilly: Key highlights
Exhibit 70: Eli Lilly: Strength assessment
Exhibit 71: Eli Lilly: Strategy assessment
Exhibit 72: Eli Lilly: Opportunity assessment
Exhibit 73: Eli Lilly: YoY revenue and growth rate of Alimta 2013-2015 ($ billions)
Exhibit 74: Eli Lilly: Geographic segmentation by revenue of Alimta 2015
Exhibit 75: Eli Lilly: YoY and growth rate of Cyramza 2014-2015 ($ millions)
Exhibit 76: Eli Lilly: Geographic segmentation by revenue of Cyramza 2015
Exhibit 77: AstraZeneca: Key highlights
Exhibit 78: AstraZeneca: Strength assessment
Exhibit 79: AstraZeneca: Strategy assessment
Exhibit 80: AstraZeneca: Opportunity assessment
Exhibit 81: AstraZeneca: YoY revenue and growth rate of Iressa 2013-2015 ($ billions)
Exhibit 82: AstraZeneca: Geographic segmentation of Iressa 2013-2015 (% share)
Exhibit 83: Pfizer: Key highlights
Exhibit 84: Pfizer: Strength assessment
Exhibit 85: Pfizer: Strategy assessment
Exhibit 86: Pfizer: Opportunity assessment
Exhibit 87: Pfizer: YoY revenue and growth rate of Xalkori 2013-2015 ($ millions)
Exhibit 88: Celgene: Key highlights
Exhibit 89: Celgene: Strength assessment
Exhibit 90: Celgene: Strategy assessment
Exhibit 91: Celgene: Opportunity assessment
Exhibit 92: Celgene: YoY revenue and growth rate of Abraxane 2013-2015 ($ millions)
【レポート販売概要】
■ タイトル：肺がん治療薬の世界市場2016-2020：NSCLC、SCLC■ 英文：Global Lung Cancer Therapeutics Market 2016-2020
■ 発行日：2016年11月18日
■ 調査会社：Technavio
■ 商品コード：IRTNTR10849
■ 調査対象地域：グローバル
- 血漿療法の世界市場：ピュアPRP（多血小板血漿）、白血球リッチPRP、ピュア多血小板フィブリン、白血球リッチフィブリンThe global plasma therapy market comprises various types of platelet-rich plasma that are used by hospitals & clinics and several research institutions. Rise in the number of orthopedic disorders associated with trauma and aging led to the increased demand for minimally-invasive therapies. This has further contributed to the increased demand for PRP in orthopedic, dermatology, nerve injury, cardia …
- 世界における小型自動車用OE(メーカー純正部品)ホイール市場動向と予測（～2029）This latest just-auto report edition offers a global review of the OE wheels sector, its suppliers, top markets, technologies and market forecasts. This global market study offers: Automotive OE wheels market size estimates Latest technologies and trends Market share data tables Exclusive interviews with major companies Profiles of the major players including their strategies and prospects Market …
- 移動式発電設備レンタルの世界市場：ジェネレータ、タービンGlobal Mobile Power Generation Equipment Rentals Market: About this market Mobile power generation equipment rentals eliminate the need of end-users for installing a permanent power solution. Technavio’s mobile power generation equipment rentals market analysis considers sales from the generator and turbine segments. Our analysis also considers the sales of mobile power generation equipment rental …
- 世界の鉛市場：市場規模、動向、メーカー動向Scope The report presents a thorough study of lead, covering both global and regional markets It aims to give a proper picture of the market, as well as its trends, perspectives and opportunities Comprehensive data showing lead production, consumption, trade statistics and prices are provided (both nationwide and worldwide) Each country’s market overview covers the following: lead production in th …
- Ventricular Arrhythmia：グローバル臨床試験レビューH2, 2013Ventricular Arrhythmia Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Ventricular Arrhythmia Global Clinical Trials Review, H2, 2013" provides data on the Ventricular Arrhythmia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ventricular Arrhythmia. It includes an overview of the trial numbers and …
- ホームオートメーションシステムの世界市場予測（～2022）：照明、セキュリティ・アクセス制御、HVAC・エンターテインメント制御The home automation system market is expected to reach USD 79.57 Billion by 2022, at a CAGR of 11.3% during the forecast period between 2017 and 2022. The growth of this market is propelled by the cost reduction measures enabled by home automation systems, the presence of a large number of manufacturers expanding their product portfolios, and the increasing importance of home monitoring from remot …
- M-キシリレン・ジイソシアネートの世界市場M-Xylylene Diisocyanate (CAS 3634-83-1) Market Research Report 2013 presents comprehensive data on m-xylylene diisocyanate markets globally and regionally (Europe, Asia, North America etc.) The M-Xylylene Diisocyanate (CAS 3634-83-1) Market Research Report 2013 includes m-xylylene diisocyanate description, covers its application areas and related patterns. It overviews m-xylylene diisocyanate mark …
- Type 2 Diabetes Therapeutics Market to 2019 – A Shifting Treatment Algorithm and Intensified Competition Expected to Drive Growth by 2019Type 2 Diabetes Therapeutics Market to 2019 - A Shifting Treatment Algorithm and Intensified Competition Expected to Drive Growth by 2019 Summary GBI Research has released its latest report for the pharmaceuticals industry, “Type 2 Diabetes Therapeutics Market to 2019 - A Shifting Treatment Algorithm and Intensified Competition Expected to Drive Growth by 2019”. There is currently a large number o …
- 世界主要国におけるエンテロウイルス検査市場2015The report presents a detailed analysis of the Enterovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Enterovirus definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - …
- オスミウム187 の世界市場2015Osmium-187 (CAS 15766-52-6) Market Research Report 2015 aims at providing comprehensive data on Osmium-187 market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes Osmium-187 description, covers its application areas, manufacturing methods, patterns. It captures Osmium-187 market trends, pays close attention to Osmium-187 manufacturers and names supplier …
- ホーム、スマートホーム：センシング制御技術の動向および市場機会Early this year, Google announced the US$3.2-billion acquisition of Nest Labs, a maker of smart home sensing control devices like thermostats and smoke alarms. This move has revealed Google's plan to enter the smart home business, offering software-hardware-service integrations. This report provides an overview of the smart home sensing control technologies, as well as major vendors' patent deploy …
- 航空貨物サービスの世界市場2016-2020About Air Cargo Air cargo services ship different kinds of goods by air to both international and domestic customers at competitive rates. Such services are provided by air cargo companies that arrange for a transfer, customs clearance, and tracking of consignments. The cargo is transported by passenger or charter aircraft. Air cargo companies or freight forwarders provide the following services: …
- イースト（酵母）の世界市場：パン用イースト、醸造イースト、ワイン用イースト、バイオエタノールイースト、飼料用イーストThe global market for yeast & specialty yeast has been growing steadily during the last few decades. In terms of value, the market is projected to reach USD 4.95 Billion by 2021, at a CAGR of 8.9% from 2016 to 2021 and is projected to reach 3,115.2 KT in terms of volume by 2021, at a CAGR of 6.9%. Rising demand for bakery products and demand for bio-ethanol as fuel are driving the market for yeast …
- BRIC（ブラジル/ロシア/インド/中国）の婦人科用医療機器市場BRIC Gynecological Devices Market Outlook to 2020 Summary GlobalData’s new report, "BRIC Gynecological Devices Market Outlook to 2020", provides key market data on the BRIC Gynecological Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Female Sterilization Devices (Transcervical Sterilization Devices …
- Operating Room Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018Operating Room Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 Summary GlobalData’s new report, “Operating Room Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018” provides key market data on the Operating Room Equipment market in the BRICS countries. The report provides value ($m), volume (units) and average price ($) data …
